Decreased activity of the guanine nucleotide regulatory protein (N) of the adenylate cyclase system is present in cell membranes of some patients with pseudohypoparathyroidism (PHP-Ia) whereas others have normal activity of N (PHP-Ib). Low N activity in PHP-Ia results in a decrease in hormone (H)-stimulatable adenylate cyclase in various tissues, which might be due to decreased ability to form an agonist-specific high affinity complex composed of H, receptor (R), and N. To test this hypothesis, we compared β-adrenergic agonist-specific binding properties in erythrocyte membranes from five patients with PHP-Ia (N = 45% of control), five patients with PHP-Ib (N = 97%), and five control subjects. Competition curves that were generated by increasing concentrations of the β-agonist isoproterenol competing with [125I]pindolol were shallow (slope factors < 1) and were computer fit to a two-state model with corresponding high and low affinity for the agonist. The agonist competition curves from the PHP-Ia patients were shifted significantly (P < 0.02) to the right as a result of a significant (P < 0.01) decrease in the percent of β-adrenergic receptors in the high affinity state from 64 ± 22% in PHP-Ib and 56 ± 5% in controls to 10 ± 8% in PHP-Ia. The agonist competition curves were computer fit to a 'ternary complex' model for the two-step reaction: H + R + N ≠ HR + N ⇆ HRN. The modeling was consistent with a 60% decrease in the functional concentration of N, and was in good agreement with the biochemically determined decrease in erythrocyte N protein activity. These in vitro findings in erythrocytes taken together with the recent observations that in vivo isoproterenol-stimulated adenylate cyclase activity is decreased in patients with PHP (Carlson, H.E., and A.S. Brickman, 1983, J. Clin. Endocrinol. Metab. 56:1323-1326) are consistent with the notion that N is a bifunctional protein interacting with both R and the adenylate cyclase. It may be that in patients with PHP-Ia a single molecular and genetic defect accounts for both decreased HRN formation and decreased adenylate cyclase activity, wereas in PHP-Ib the biochemical lesion(s) appear not to affect HRN complex formation.
|Original language||English (US)|
|Number of pages||9|
|Journal||Journal of Clinical Investigation|
|State||Published - 1984|
ASJC Scopus subject areas